Metformin for the Treatment of Diabetes in Pregnancy
Phase 3
- Conditions
- Gestational DiabetesDiabetes Mellitus Type 2
- Registration Number
- NCT00414245
- Lead Sponsor
- Soroka University Medical Center
- Brief Summary
The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
- pregnant women
- GDM A2
- diabetes mellitus type 2
- singleton pregnancy
Exclusion Criteria
- diabetic nephropathy or proliferative retinopathy
- cannot swallow tablets
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method glycemic control pregnancy complications
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie metformin's efficacy in gestational diabetes mellitus?
How does metformin compare to insulin in managing hyperglycemia during pregnancy?
Are there specific biomarkers that predict metformin response in type 2 diabetes patients during pregnancy?
What are the potential adverse events associated with metformin use in gestational diabetes and how can they be managed?
What combination therapies or alternative drugs are being explored alongside metformin for diabetes in pregnancy?
Trial Locations
- Locations (1)
Division of Obstetrics and Gynecology, Soroka University Medical Center
🇮🇱Beer-Sheva, Israel
Division of Obstetrics and Gynecology, Soroka University Medical Center🇮🇱Beer-Sheva, IsraelBoaz Sheizaf, MDPrincipal Investigator